Asymmetric dimethylarginine

LE WE PMID CA

Asymmetric dimethylarginine

4062

Asymmetrisches Dimethylarginin

Angiogenesis

Asymmetric dimethylarginine

Cardiovascular risk

CAT1 (Transporter)

DDAH1 dimethylarginine dimethylaminohydrolase1

Endothelial dysfunction

Kidney (Progression of renal disease)

Myelin basic protein MBP

Nitric oxide NO

nNOS

Peroxynitrite

Protein (ptm Tyrosine nitration)

Transporter (Amino acid)

2003 1	The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. [14553822] Cardiovasc Res 59(4): 824-33 (2003)
1999 2	Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. [10690326] Cardiovasc Res 43(3): 542-8 (1999)
2004 3	Elimination of asymmetric dimethylarginine by the kidney and the liver: a link to the development of multiple organ failure? [15465798] J Nutr 134(10 Suppl): 2848S-2852S; discussion 2853S (2004)
2004 4	Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor. [15465797] J Nutr 134(10 Suppl): 2842S-2847S; discussion 2853S (2004)
2008 5	Asymmetrical dimethylarginine in renal disease: limits of variation or variation limits? A systematic review. [17960061] Am J Nephrol 28(2): 224-37 (2008)
2005 6	L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor. [15771559] Altern Med Rev 10(1): 14-23 (2005)
2011 7	Asymmetric dimethylarginine: a novel biomarker of gastric mucosal injury? [21633526] World J Gastroenterol 17(17): 2178-80 (2011)
2010 8	A miR-thless perspective: how asymmetric dimethylarginine impairs the functions of angiogenic progenitor cells. [20616336] Circ Res 107(1): 12-4 (2010)
2003 9	When the endothelium cannot say 'NO' anymore. ADMA, an endogenous inhibitor of NO synthase, promotes cardiovascular disease. [14585247] Eur Heart J 24(21): 1901-2 (2003)
2007 10	Should we measure asymmetric dimethylarginine in patients with coronary artery disease? [17259245] Clin Chem 53(2): 161-3 (2007)
2006 11	Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy. [16702618] Pharmacol Rep 58(2): 159-78 (2006)
2006 12	Asymmetric dimethylarginine (ADMA) a novel cardiovascular risk factor--evidence from epidemiological and prospective clinical trials. [17332667] Pharmacol Rep 58 Suppl(-): 16-20 (2006)
2009 13	Asymmetric dimethylarginine (ADMA) and endothelial dysfunction: implications for atherogenesis. [19488614] Clinics (Sao Paulo) 64(5): 471-8 (2009)
2008 14	Role of asymmetric dimethylarginine in cardiovascular disease and diabetes. [20477387] Biomark Med 2(4): 317-20 (2008)
2009 15	Effect of peroxynitrite on endothelial L-arginine transport and metabolism. [19695340] Int J Biochem Cell Biol 41(12): 2522-7 (2009)
2010 16	New pathways to renal damage: role of ADMA in retarding renal disease progression. [20349427] J Nephrol 23(4): 377-86 (2010)
2009 17	Cellular ADMA: regulation and action. [19682580] Pharmacol Res 60(6): 448-60 (2009)
2007 18	Asymmetric dimethylarginine (ADMA)--a modulator of nociception in opiate tolerance and addiction? [17625935] Nitric Oxide 17(2): 55-9 (2007)
2010 19	The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature. [20923854] Eur J Heart Fail 12(12): 1274-81 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Asymmetric dimethylarginine.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Asymmetric dimethylarginine.php on line 92